Since BRCA1 and BRCA2 were cloned five years ago, unraveling their normal f
unctions has posed fascinating problems for cancer biologists. Bath genes a
re novel, and little of their normal function was revealed by their sequenc
e. Both genes contribute to homologous recombination and DNA repair, to emb
ryonic proliferation, to transcriptional regulation and, for BRCA1, to ubiq
uitination. But questions regarding BRCA1 and BRCA2 biology remain, and the
ir resolution is critical for clinical development. Why do ubiquitously exp
ressed genes that participate in universal pathways lead, when mutant, spec
ifically to breast and ovarian cancer? Why are the same genes required for
embryonic proliferation and for tumor suppression?